-
Study aim
-
To compare the efficacy and safety of intravenous low-dose ketamine versus intravenous paracetamol for preventing shivering after spinal anesthesia.
-
Design
-
Single-center, prospective, two-arm, parallel-group, double-blind randomized controlled trial of 80 patients (40 per group). Allocation was 1:1 using a computer-generated sequence and sequentially numbered, opaque, sealed envelopes.
-
Settings and conduct
-
Conducted in the operating rooms and post-anesthesia care unit of Shohadaye Tajrish Hospital, Tehran, Iran. Patients received standardized perioperative monitoring. Participants and outcome assessors were blinded; an independent anesthesiologist prepared the study drugs.
-
Participants/Inclusion and exclusion criteria
-
Adults aged 18–65 years, American Society of Anesthesiologists (ASA) physical status I–II, undergoing elective lower abdominal or lower-limb surgery under spinal anesthesia were included. Major exclusions were relevant drug allergy, significant cardiovascular, respiratory, hepatic or renal disease, pregnancy, and conditions affecting outcome assessment.
-
Intervention groups
-
Intervention group: Intravenous ketamine 0.25 mg/kg once.
Control group: Intravenous paracetamol 15 mg/kg (maximum 1 g) once.
Both were infused over 5–10 minutes immediately after completion of spinal anesthesia.
-
Main outcome variables
-
Primary outcome: clinically visible shivering (Crossley–Mahajan grade ≥2) within 60 minutes after spinal anesthesia. Secondary outcomes: maximum shivering grade, time to first detected shivering, heart rate, mean arterial pressure, oxygen saturation, adverse events, and rescue meperidine use. Shivering was assessed at 0, 5, 10, 15, 30, 45, and 60 minutes.